|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn952772313 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
110322s2011 nyua ob 001 0 eng |
| 010 |
|
|
|a 2019714320
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|e pn
|c DLC
|d UMMBL
|d OCLCO
|d N$T
|d YDXCP
|d OCLCF
|d NLGGC
|d D6H
|d MERUC
|d AGLDB
|d ZCU
|d VTS
|d COCUF
|d TOF
|d AU@
|d WYU
|d REC
|d VT2
|d STF
|d K6U
|d OCLCA
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCO
|
| 016 |
7 |
|
|a 015875048
|2 Uk
|
| 019 |
|
|
|a 779844104
|a 1066598908
|a 1081262926
|
| 020 |
|
|
|a 9781620810453
|q (ebook)
|
| 020 |
|
|
|a 162081045X
|
| 020 |
|
|
|z 1613244444
|q (hardcover ;
|q alk. paper)
|
| 020 |
|
|
|z 9781613244449
|q (hardcover ;
|q alk. paper)
|
| 029 |
1 |
|
|a AU@
|b 000051577234
|
| 029 |
1 |
|
|a DEBBG
|b BV043165211
|
| 029 |
1 |
|
|a DEBSZ
|b 421440740
|
| 035 |
|
|
|a (OCoLC)952772313
|z (OCoLC)779844104
|z (OCoLC)1066598908
|z (OCoLC)1081262926
|
| 050 |
0 |
0 |
|a QR189.5.D53
|
| 060 |
|
4 |
|a QW 805
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 615/.372
|2 22
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a DNA vaccines :
|b types, advantages, and limitations /
|c Erin C. Donnelly and Arthur M. Dixon, editors.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical Books,
|c ©2011.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Immunology and immune system disorders
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a DNA VACCINES: TYPES, ADVANTAGES AND LIMITATIONS ; IMMUNOLOGY AND IMMUNE SYSTEM DISORDERS ; DNA VACCINES: TYPES, ADVANTAGES AND LIMITATIONS ; Contents ; Preface ; Novel Carrier Adjuvant for DNA Vaccination ; Abstract ; 1. Introduction ; 2. Immunology of DNA Vaccines: Mode of Action and Immune Response Induction ; 3. Barriers in DNA Vaccine Delivery and Possible Modes to Overcome these Barriers ; 4. Novel Strategies for DNA Delivery ; 4.1. Lipid Based Carrier Adjuvants for DNA Vaccination ; 4.1.1. Liposomes ; 4.1.2. Virosomes.
|
| 505 |
8 |
|
|a 4.2. Polymers and Polymeric Carriers Systems 4.2.1. Polyethylenimine ; 4.2.2. Polylysine ; 4.2.3. Chitosan ; 4.2.4. Dendrimers ; 5. Concluding Remark and Future Prospects ; References ; Improving the Immunogenicity of DNA Vaccines: A Nano-Sized Task? ; Abstract ; Introduction ; Improving Immunogenicity of Plasmid DNA Vaccines ; Routes of Delivery of Plasmid DNA Vaccines ; Physical Delivery Systems of Plasmid DNA Vaccines ; Needle-Free Delivery Methods ; Expression Optimization ; Cytokines ; Delivery Vectors for DNA Vaccines ; Bacterial Vectors ; Viral Vectors.
|
| 505 |
8 |
|
|a DNA and RNA Replicons Nano-Sized Vehicles for Gene Delivery ; Inorganic to Biomaterial -- Past to Future ; Size Determines the Fate of Particles ; Conclusion ; References ; Novel Delivery Strategies for DNA ; Abstract ; I. Introduction ; II. Optimization of Immunogenicity of DNA Vaccines ; 2.1. Choice of Targets and Expression Plasmid for DNA Vaccines ; 2.2. Selection of High Expression Plasmids for DNA Vaccines ; 2.3. Codon Optimization for Higher Gene Expression ; 2.4. Adjuvant Choice for DNA Vaccines ; III. DNA Delivery Strategies ; 3.1. Invasive Delivery.
|
| 505 |
8 |
|
|a 3.1.1. Needle Injection 3.1.2. In Vivo Electroporation ; 3.1.3. Tattoo Gun Delivery ; 3.2. Non-Invasive Topical Delivery Method ; 3.2.1. Tape Stripping ; 3.2.2. Nanopatch Delivery ; 3.2.3. Nano-Particle Mediated Delivery ; 3.3. Viral-Mediated DNA Delivery Systems ; 3.4. Non-Viral Gene Delivery Systems ; 3.5. Novel Delivery Methods ; 3.5.1. Laser Mediated Delivery ; 3.5.2. Ultrasound Mediated Delivery System ; III. Future Directions ; References ; Recent Advances in DNA Vaccines ; Abstract ; Introduction ; DNA Vaccines X Traditional Vaccine Approaches ; Components of a DNA Vaccine.
|
| 505 |
8 |
|
|a How DNA Vaccines Work Delivery Methods ; Advantages X Limitations ; Strategies to Enhance Immunogenicity of DNA Vaccines ; Modifications of Plasmid Basic Design ; Delivery Methods ; Target to Dendritic Cells ; Improved Immunization Protocols ; Adjuvants ; Conclusion ; References ; Co-Administration of Gamma Interferon Gene with DNA Vaccine Expressing Duck Hepatitis B Virus (DHBV) Proteins Enhances Therapeutic Efficacy of DNA-Based Immunization in Chronic Virus Carriers ; Abstract ; Introduction ; Materials and Methods ; Animals ; DNA Immunization.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a DNA vaccines.
|
| 650 |
|
2 |
|a Vaccines, DNA
|
| 650 |
|
6 |
|a Vaccins à ADN.
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a DNA vaccines
|2 fast
|
| 700 |
1 |
|
|a Donnelly, Erin C.
|
| 700 |
1 |
|
|a Dixon, Arthur M.
|
| 776 |
0 |
8 |
|i Print version:
|t DNA vaccines.
|d New York : Nova Biomedical Books, ©2011
|z 9781613244449
|w (DLC) 2011012604
|
| 830 |
|
0 |
|a Immunology and immune system disorders.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=439182
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3021072
|
| 938 |
|
|
|a ebrary
|b EBRY
|n ebr10681272
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 439182
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 7561576
|
| 994 |
|
|
|a 92
|b IZTAP
|
